Characterization of the GHB Withdrawal Syndrome

The gamma-hydroxybutyric acid (GHB) withdrawal syndrome can have a fulminant course, complicated by severe complications such as delirium or seizures. Detoxification by tapering with pharmaceutical GHB is a safe way to manage GHB withdrawal. However, a detailed description of the course of the GHB w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Casper J. H., Beurmanjer, Harmen, Dijkstra, Boukje A. G., Geerlings, Alexander C., Spoelder, Marcia, Homberg, Judith R., Schellekens, Arnt F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199158/
https://www.ncbi.nlm.nih.gov/pubmed/34073640
http://dx.doi.org/10.3390/jcm10112333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199158/
https://www.ncbi.nlm.nih.gov/pubmed/34073640
http://dx.doi.org/10.3390/jcm10112333

Ejemplares similares